Sign Up for our Newsletter

Noninvasive prenatal testing for greater accuracy
More women deserve the right to NIPT
Expert Insights & Resources
Expand your knowledge with articles, training resources, news & webcasts for professionals and advocates alike.
What You Can Screen For
Trisomy 21 (Down syndrome)
Trisomy 18 (Edwards syndrome)
Trisomy 13 (Patau syndrome)
Vanadis® NIPT platform: Built for All
Unlike complex and expensive sequencing-based platforms, Vanadis NIPT enables cost-efficient and high-performance screening for fetal aneuploidies. Making cell-free DNA testing accessible to more laboratories and more women, Vanadis is built for all.
Easy
Precise
Cost-Effective
Featured Products
Other prenatal screening solutions

Pre-eclampsia Management
Learn more
Serum Screening
Learn more
Sign up for our newsletter
Stay up-to-date on the latest developments related to noninvasive prenatal testing.
Take the next step
Speak with a sales person
Talk to one of our product experts about the right solutions for you.
View more resources
Explore our articles and resources section for the latest information.
Read the lastest news
Sign up for our newsletter to find out about the latest news from PerkinElmer and the industry.
References
- Practice Bulletin Number 226: Screening for fetal chromosomal abnormalities. Obstet Gynecol. 2020; 136(4)
- Benn P, Borrell A, Chiu R, et al. Position statement from the Chromosome Abnormality Screening Committee. Prenat Diagn. 2015;35(8):725-734.
Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.